Scientists are starting to elucidate the roots of gastrointestinal symptoms that appear after a meal in people with irritable bowel syndrome. Current research highlights the immune drivers of gut pain, which could offer clues on how to treat IBS.
The fourth edition of IBS Days covered the latest IBS diagnosis and treatment advances in a postgraduate course. Read about the highlights and discussions (part 2).
IBS Days 2024: what’s new in the pathophysiology of IBS, overlapping conditions, and non-prescription microbiome-based therapeutics?
12 Aug 2024by Andreu Prados
June 17-19 2024, Gut Microbiota for Health attended the fourth edition of IBS Days 2024 in Bologna, Italy, alongside 400 in-person attendees. Find out more about the most relevant basic, translational, and clinical science highlights in IBS (part 1).
Why addressing how our brain and our gut talk to each other matter for IBS
19 Feb 2024by Premysl Bercik, Andreu Prados
While the idea that our gut can influence our brain is not new, this is a rapidly growing area of research. Find out more on how gut microbes influence anxiety and stress and why tackling these psychological traits matters for irritable bowel syndrome.
Diets for irritable bowel syndrome: what you need to know
20 Dec 2023by Andreu Prados, Kate Scarlata
Food is considered the main trigger of digestive symptoms in the vast majority of patients living with IBS. While finding foods that do not prompt gastrointestinal (GI) symptoms has been a challenge for many people with IBS, restrictive diets can come with potential risks. Learn more about diets with evidence in IBS.
Diagnosing IBS and targeting gut microbiota and metabolites to improve symptoms
18 Oct 2023by Andrea Costantino
Chronic abdominal pain, diarrhea, constipation, and bloating are common gastrointestinal symptoms. While a structural or an organic disease can be suspected because of the symptoms and is often easy to be diagnosed by endoscopy or imaging methods, sometimes gastrointestinal symptoms are not related to any alteration that may be seen through diagnostic techniques, and consequently have been classified under the umbrella of “disorders of gut-brain interaction”.
Clues provided by the microbiota-gut-brain connection may help improve IBS diagnosis and management
2 Jan 2023by GMFH Editing Team
Dr. James Versalovic updates what we know so far about the contribution of an altered gut microbiota to the development of the IBS and the available science-backed tools for relieving symptoms.
Yeast probiotics for the management of gastrointestinal symptoms of IBS
27 Sep 2022by Andreu Prados
Bacteria and fungi in the human gut microbiota may contribute to the underlying mechanisms of IBS, which means the latter can be explored as a potential target for IBS. This article explores what is known about the role of the gut microbiome and yeast probiotics in irritable bowel syndrome.
Long-term diet may affect the inflammatory effects of the gut microbiome more than specific foods alone
8 Sep 2021by Allison Clark
The purpose of the article is to uncover how dietary components and long-term dietary patterns interact with and influence gut microbiota composition and function and intestinal inflammation.
Poor eating habits and gut microbes’ carbohydrate metabolism can drive IBS symptom severity
14 Jun 2021by Joël Doré
Little is known about the relationship between diet, the composition and function of the gut microbiota and clinical symptoms of IBS. New findings identify how IBS symptom severity is related to a higher intake of foods with poor nutritional quality and gut microbiome features at both subspecies level and metabolic pathways involved in carbohydrate metabolism.
